| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acetyl-l-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network
|
Callander, Natalie
|
|
2014
|
74 |
4 |
p. 875-882
|
artikel
|
| 2 |
Anticancer activity of VDR-coregulator inhibitor PS121912
|
Sidhu, Preetpal S.
|
|
2014
|
74 |
4 |
p. 787-798
|
artikel
|
| 3 |
A pharmacodynamic model of Bcr–Abl signalling in chronic myeloid leukaemia
|
Jackson, Robert C.
|
|
2014
|
74 |
4 |
p. 765-776
|
artikel
|
| 4 |
A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancer
|
Kim, Hee Man
|
|
2014
|
74 |
4 |
p. 861-865
|
artikel
|
| 5 |
A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancer
|
Zhang, Qiang
|
|
2014
|
74 |
4 |
p. 839-846
|
artikel
|
| 6 |
Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal model
|
Costa, Marcelo Leite Vieira
|
|
2014
|
74 |
4 |
p. 711-720
|
artikel
|
| 7 |
First-line gefitinib therapy for elderly patients with non-small cell lung cancer harboring EGFR mutation: Central Japan Lung Study Group 0901
|
Takahashi, Kosuke
|
|
2014
|
74 |
4 |
p. 721-727
|
artikel
|
| 8 |
Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies
|
Machiels, Jean-Pascal
|
|
2014
|
74 |
4 |
p. 729-737
|
artikel
|
| 9 |
Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma
|
Motzer, Robert J.
|
|
2014
|
74 |
4 |
p. 739-750
|
artikel
|
| 10 |
Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer
|
Macedo-Pérez, Eleazar Omar
|
|
2014
|
74 |
4 |
p. 681-690
|
artikel
|
| 11 |
Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study
|
Akgun, Zuleyha
|
|
2014
|
74 |
4 |
p. 751-756
|
artikel
|
| 12 |
Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil
|
Jamieson, David
|
|
2014
|
74 |
4 |
p. 667-674
|
artikel
|
| 13 |
Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children’s Oncology Group
|
Thompson, Patrick
|
|
2014
|
74 |
4 |
p. 831-838
|
artikel
|
| 14 |
Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
|
Park, Ji Soo
|
|
2014
|
74 |
4 |
p. 799-808
|
artikel
|
| 15 |
Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study
|
Kobayashi, Shogo
|
|
2014
|
74 |
4 |
p. 699-709
|
artikel
|
| 16 |
Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors
|
Garg, Amit
|
|
2014
|
74 |
4 |
p. 819-829
|
artikel
|
| 17 |
Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy
|
Li, Zheng
|
|
2014
|
74 |
4 |
p. 777-786
|
artikel
|
| 18 |
Pretherapeutic uracil and dihydrouracil levels in saliva of colorectal cancer patients are associated with toxicity during adjuvant 5-fluorouracil-based chemotherapy
|
Carlsson, Göran
|
|
2014
|
74 |
4 |
p. 757-763
|
artikel
|
| 19 |
Resistance to the antiproliferative effect induced by a short-chain ceramide is associated with an increase of glucosylceramide synthase, P-glycoprotein, and multidrug-resistance gene-1 in cervical cancer cells
|
Gutiérrez-Iglesias, Gisela
|
|
2014
|
74 |
4 |
p. 809-817
|
artikel
|
| 20 |
Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy
|
Keefe, Dorothy M.
|
|
2014
|
74 |
4 |
p. 675-680
|
artikel
|
| 21 |
Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?
|
Chiu, Chao-Hua
|
|
2014
|
74 |
4 |
p. 661-665
|
artikel
|
| 22 |
The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma
|
Soares, Ana S.
|
|
2014
|
74 |
4 |
p. 847-860
|
artikel
|
| 23 |
The effect of formulation and food consumption on the bioavailability of dovitinib (TKI258) in patients with advanced solid tumors
|
Sharma, Sunil
|
|
2014
|
74 |
4 |
p. 867-874
|
artikel
|
| 24 |
Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
|
Xia, Chang
|
|
2014
|
74 |
4 |
p. 691-697
|
artikel
|
Tijdschrift beschrijving